Chan Frank (CIK 2061743) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell HAE (546 shares), Buy HAE (27,535 shares), Buy HAE (5,689 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Operating Officer | Sell | 546 | $30,734 |
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Operating Officer | Buy | 27,535 | $0 |
| 2025-05-20 | HAEMONETICS CORP (HAE) | EVP, Chief Operating Officer | Buy | 5,689 | $0 |
Source: SEC Form 4 filings · as of 2026-05-19